Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Ombitasvir-d16 is labelled Ombitasvir (O633200), which is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. Ombitasvir inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion.
?您的位置：
